Condition: Locally Advanced Cervical Carcinoma · Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
To evaluate the degree of acute and long-term intestinal, urinary and vaginal toxicity, and the impact on sexual activity of an accelerated fractionation of high dose rate interventional radiotherapy (IRT-HDR) in patients with locally advanced cervical cancer (IB2 - VA, N+/-).
This description comes directly from the study's public registry record.
VALENTINA LANCELLOTTA · 3441177911 · valentina.lancellotta@policlinicogemelli.it
Always discuss trial participation with your own doctor first.
| Fondazione Policlinico Universitario A. Gemelli, IRCCS | Rome, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06398938